Results 1 to 10 of about 609,595 (394)
PLoS ONE, 2021 Background Despite a remarkable progress in the reduction of global rate of maternal mortality, cervical cancer has been identified as the leading cause of maternal morbidity and mortality, particularly in sub-Saharan African countries.
Melaku Desta +8 more
doaj +3 more sources
Ca-A Cancer Journal for Clinicians, 2020 The American Cancer Society (ACS) recommends that individuals with a cervix initiate cervical cancer screening at age 25 years and undergo primary human papillomavirus (HPV) testing every 5 years through age 65 years (preferred); if primary HPV testing ...
Carmen E Guerra +2 more
exaly +2 more sources
Cervical cancer screening data from the case-based national electronic registry in Bangladesh [PDF]
BMC Global and Public HealthBackground The Government of Bangladesh established a visual inspection with acetic acid (VIA)-based cervical cancer screening programme at 600 primary, secondary and tertiary health facilities following a pilot programme in 2005.
Ashrafun Nessa +5 more
doaj +2 more sources
Knowledge and utilization of screening for cervical cancer among female in Ethiopia: a systemic review and meta-analysis [PDF]
World Cancer Research Journal, 2021 Objective: The aim of this systemic review and meta-analysis was to verify that whether knowledge about screening for cervical cancer related with usage of screening for cervical cancer among female in Ethiopia.
T. Kaleab +3 more
doaj +1 more source
Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic
eLife, 2023 Background: At the onset of the COVID-19 pandemic cervical screening in the capital region of Sweden was canceled for several months. A series of measures to preserve and improve the cervical screening under the circumstances were instituted, including a
Miriam Elfström +2 more
doaj +1 more source
HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK
Pathogens, 2023 Cervical cancer is the fourth most common malignancy in females worldwide, and a leading cause of death in the United Kingdom (UK). The human papillomavirus (HPV) is the strongest risk factor for developing cervical intraepithelial neoplasia and cancer ...
Sunyoung Choi +3 more
semanticscholar +1 more source
JAMA Network Open, 2022 Key Points Question What proportion of screening-eligible women do not have up-to-date US Preventive Services Task Force guideline–concordant cervical cancer screening status, and what are their primary reasons for not receiving timely screening ...
Ryan Suk +5 more
semanticscholar +1 more source
European Journal of Medical Research, 2023 Background Primary human papillomaviruses (HPV) cervical cancer screening can be strengthened by offering home-collection of biological specimen as a valuable option to increase screening coverage.
Giulia Feltri +17 more
doaj +1 more source
Artificial Intelligence in Cervical Cancer Screening and Diagnosis
Frontiers in Oncology, 2022 Cervical cancer remains a leading cause of cancer death in women, seriously threatening their physical and mental health. It is an easily preventable cancer with early screening and diagnosis.
X. Hou +5 more
semanticscholar +1 more source
BMC Women's Health, 2022 Objectives Low-and-middle-income countries (LMICs) bear a disproportionate burden of cervical cancer mortality. We aimed to identify what is currently known about barriers to cervical cancer screening among women in LMICs and propose remedial actions ...
Z. Petersen +12 more
semanticscholar +1 more source